17-丁酸氢化可的松

17-丁酸氢化可的松（CAS 13609-67-1）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的理化数值

在册的记载用途

For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.Drugs used to treat or prevent skin disorders or for the routine care of skin.

同义词与商品名

hydrocortisone butyrate; Hydrocortisone 17-butyrate; 13609-67-1; Cortisol 17-butyrate; Locoid; Hydrocortisone-17-butyrate; Hydrocortisone-17alpha-butyrate; Locoid Lipocream; 17-O-butyrylcortisol; DTXSID4045896; 05RMF7YPWN; H-17-B; 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate; CHEBI:31674; NSC-758433; 11beta,21-dihydroxy-3,20-dioxopregn-4-en-17-yl butanoate

已收录的法规名录

GHS notification summary	16.7% (1 / 6)

GHS 危害分类

GHS notification summary	16.7% (1 / 6)
Reported hazard statements	H302, H312, H332 (16.7%), H315 (33.3%), H319 (33.3%), H341 (16.7%), H361 (16.7%), H373 (16.7%)

This chemical does not meet GHS hazard criteria for 16.7% (1 of 6) of reports.

H302+H312+H332 (16.7%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]

公开数据库对它的描述

hydrocortisone 17-butyrate · CAS 13609-67-1 · C25H36O6. UNII 05RMF7YPWN. LogP: 3.18.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。